Pesticide spraying bracelet device

Abstract

The utility model relates to a medicine spraying bracelet device, which is used for psychiatric patients and comprises a main body unit, a watchband unit, a base unit, a medicine spraying unit, at least one driving unit and a control unit. The pesticide spraying device has the advantages that the base unit is connected with the driving unit and the pesticide spraying unit and covers the driving unit and the pesticide spraying unit, the pesticide spraying unit can be driven to slide relative to the main body unit, water can be prevented, and the installation space is saved; the medicine spraying unit is in sliding connection with the main body unit, so that calming medicine can be sprayed to the hands of a patient in time to paralyze the hands temporarily, violent behaviors of the patient on others are disturbed, and the situation that the medicine enters the main body unit to damp the main body unit can be avoided; the problem that a psychopath lacks a timely intervention device when applying violence to others is solved.

Description

Technical Field

[0001] This utility model relates to the field of wristband technology, and in particular to a spray wristband device for use by mental patients. Background Technology

[0002] During an episode, patients with mental illness often exhibit symptoms such as emotional agitation and loss of behavioral control. In some cases, they may commit violence against others, leading to serious consequences. This not only threatens the patient's own safety but may also harm those around them. Therefore, a significant challenge in the treatment and management of patients with mental illness is how to effectively control sudden acts of violence to protect the safety of both the patient and those around them.

[0003] Currently, the behavior of mental patients is mainly monitored through monitoring devices. When a mental patient is detected committing violent acts against others, the control system will issue an alert, and staff will arrive at the scene in time to stop it. However, there are no devices that can promptly interfere with the patient's behavior. Therefore, the existing handling methods are often delayed and cannot prevent the violence from taking place. By the time staff arrive at the scene, the violent acts against others have often already occurred or ended, and the staff's on-site intervention also poses a threat to their safety.

[0004] There is no effective solution yet to address the lack of timely intervention devices when mentally ill patients commit violence against others in related technologies. Utility Model Content

[0005] The purpose of this invention is to address the shortcomings of existing technologies by providing a spray wristband device to solve the problem of a lack of timely intervention devices when mentally ill patients commit violence against others.

[0006] To achieve the above objectives, the technical solution adopted by this utility model is as follows:

[0007] A spray wristband device for use by mental patients, comprising:

[0008] The main unit is worn on the patient's wrist;

[0009] The watch strap unit has two ends connected to the two sides of the main body unit, respectively, for fixing the main body unit to the patient's wrist;

[0010] A base unit, wherein the base unit is disposed inside the main body unit;

[0011] A drug spraying unit, the top of which is connected to the bottom of the base unit, and the bottom of which is slidably connected to the bottom of the main body unit, is used to spray a sedative drug onto the patient's wrist to cause temporary numbness in the patient's hand.

[0012] At least one drive unit, the top end of which is connected to the base unit and the bottom end of which is connected to the bottom end of the main body unit, for driving the base unit to drive the drug spraying unit to reciprocate.

[0013] The control unit is located inside the main body unit and is connected to the drug injection unit and the drive unit, respectively.

[0014] In some embodiments, the main body unit includes:

[0015] The housing element has two sides connected to the watch strap unit, and the housing element contains the base unit, the drug injection unit, the drive unit, and the control unit.

[0016] An opening element is provided at the bottom end of the housing element;

[0017] A sealing element, disposed on the opening element, for sealing the opening element;

[0018] A first mounting element is disposed on the sealing element and slidably connected to the drug spraying unit for mounting the drug spraying unit.

[0019] In some embodiments, the watchband unit includes:

[0020] The watch strap element has two ends connected to the two sides of the main body unit, and is worn on the patient's wrist to secure the main body unit.

[0021] In some embodiments, the watchband unit further includes:

[0022] A plurality of heat dissipation elements are distributed on the watch strap element to prevent the wrist from sweating.

[0023] In some embodiments, the base unit includes:

[0024] A base element is disposed inside the main body unit, and the bottom end of the base element is connected to the top end of the drug injection unit and the top end of the drive unit, respectively.

[0025] In some embodiments, the base unit further includes:

[0026] A waterproof element covers the base element, the drug spraying unit, and the drive unit. The bottom end of the waterproof element is connected to the bottom end of the main body unit for waterproofing.

[0027] In some embodiments, the drug dispensing unit includes:

[0028] The first drug storage element has its top end connected to the bottom end of the base unit, and its bottom end slidably connected to the bottom end of the main body unit, for storing sedative drugs.

[0029] A drug-injecting element is disposed at the bottom end of the first drug storage element and is slidably connected to the bottom end of the main body unit for spraying sedative drugs onto the patient's wrist.

[0030] A support element, the two ends of which are respectively connected to the bottom end of the base unit, the top end of which is respectively connected to the bottom end of the base unit and the bottom end of the drive unit, the bottom end of which is connected to the main body unit and slidably connected to the bottom end of the first drug storage element;

[0031] A pump element is disposed on the support element and connected to the control unit, for driving the drug spraying element to spray drug under the action of the control unit.

[0032] In some embodiments, the driving unit includes:

[0033] A sliding rod element is disposed on the side of the drug injection unit, and the top end of the sliding rod is connected to the bottom end of the base unit for pushing the base unit to reciprocate.

[0034] A fixed rod element, wherein the fixed rod is disposed at the bottom end of the sliding rod element and slides relative to the sliding rod;

[0035] A driving element is disposed at the bottom end of the fixed rod element and is connected to the sliding rod element, the drug injection unit, and the control unit respectively, for driving the sliding rod to perform reciprocating motion.

[0036] In some embodiments, the control unit includes:

[0037] A control element is disposed in the main body unit and is connected to the drug injection unit and the drive unit respectively;

[0038] A communication element is disposed in the main body unit and connected to the control element for information transmission;

[0039] A power supply element is disposed in the main body unit and connected to the control unit for supplying power.

[0040] In some embodiments, the drug dispensing unit further includes:

[0041] A first valve element is disposed at the bottom end of the first drug storage element and connected to the control unit, for controlling whether the first drug storage element outputs drug.

[0042] In some embodiments, the drug dispensing unit further includes:

[0043] A limiting element is disposed at the bottom end of the first drug storage element and is connected to the fixing element for limiting the range of motion of the first drug storage element.

[0044] In some embodiments, the drug dispensing unit further includes:

[0045] A reset element is sleeved on the first drug storage element and located at the top of the fixing element, used to assist in resetting the first drug storage element.

[0046] In some embodiments, the drug dispensing unit further includes:

[0047] A first pressure monitoring element is disposed at the top of the first drug storage element and connected to the control unit, for monitoring the gas pressure inside the first drug storage element.

[0048] In some embodiments, the spraying wristband device further includes:

[0049] A drug supply unit is disposed inside the main body unit and connected to the drug injection unit, for delivering sedative drugs to the drug injection unit under negative pressure.

[0050] In some embodiments, the spraying wristband device further includes:

[0051] A health monitoring unit is disposed in the main unit and connected to the control unit for monitoring the patient's health information.

[0052] In some embodiments, the spraying wristband device further includes:

[0053] A positioning unit is disposed in the main body unit and connected to the control unit, and is used to acquire the patient's location information.

[0054] In some embodiments, the main body unit further includes:

[0055] The second mounting element is disposed on the side of the main body unit and is used to mount the drug supply unit.

[0056] In some embodiments, the main body unit further includes:

[0057] The third mounting element is disposed at the bottom of the main body unit and is used to mount the health monitoring unit.

[0058] In some embodiments, the drug dispensing unit further includes:

[0059] A first delivery element is disposed at the top of the drug injection unit and connected to the drug supply unit for delivering gas or drug to the drug injection unit.

[0060] In some embodiments, the drug delivery unit includes:

[0061] The second drug storage element is disposed on the base unit and communicates with the drug injection unit, and is used to replenish the drug injection unit with sedative drug after the drug injection unit injects the drug.

[0062] The second delivery element has a first end connected to the bottom end of the second drug storage element and a second end connected to the top end of the drug injection unit, for delivering the sedative drug from the second drug storage element to the drug injection unit;

[0063] The third delivery element, the first end of which is connected to the top end of the second drug storage element, is used to deliver gas to the second drug storage element in a timely manner when the second drug storage element outputs sedative drugs in order to balance the pressure of the second drug storage element.

[0064] An air intake element is disposed on the side of the main body unit and communicates with the outside of the main body unit and with the second end of the third conveying element, for conveying air to the third conveying element.

[0065] In some embodiments, the drug delivery unit further includes:

[0066] A second valve element, disposed on the second delivery element and connected to the control unit, is used to prevent the drug from the drug injection unit from flowing back into the drug supply unit.

[0067] In some embodiments, the drug delivery unit further includes:

[0068] A third valve element is disposed on the third conveying element and connected to the control unit for controlling the opening and closing of the third conveying element.

[0069] In some embodiments, the drug delivery unit further includes:

[0070] A filter element is disposed at the end of the air intake element and connected to the main body unit for filtering the air entering the air intake element.

[0071] In some embodiments, the drug delivery unit further includes:

[0072] A second pressure monitoring element is disposed in the second drug storage element and connected to the control unit for monitoring the gas pressure inside the second drug storage element.

[0073] In some embodiments, the drug delivery unit further includes:

[0074] A fourth delivery element, the first end of which is connected to the second drug storage element, and the second end of which is connected to the main body unit, for delivering sedative drugs to the second drug storage element;

[0075] A liquid inlet element is connected to the second end of the fourth delivery element and to the side of the main body unit, for delivering drugs to the fourth delivery element;

[0076] A fourth valve element is disposed at the second end of the fourth conveying element and connected to the control unit for controlling the opening and closing of the fourth conveying element.

[0077] The present invention adopts the above technical solution and has the following technical effects compared with the prior art:

[0078] This utility model discloses a spray wristband device. A base unit is connected to a drive unit and a drug spraying unit, respectively, and covers both units. This not only allows the drug spraying unit to slide relative to the main unit but also provides waterproofing and saves installation space. The sliding connection between the drug spraying unit and the main unit allows for timely spraying of sedative medication onto the patient's hand to temporarily paralyze them and prevent them from committing acts of violence against others. It also prevents the medication from entering the main unit and causing it to become damp, thus solving the problem of a lack of timely intervention devices when mentally ill patients commit violence against others. Attached Figure Description

[0079] Figure 1 This is a schematic diagram (a) of the spraying wristband device according to an embodiment of the present utility model;

[0080] Figure 2 This is a schematic diagram (a) of the main body unit according to an embodiment of the present utility model;

[0081] Figure 3 This is a schematic diagram of a watch strap unit according to an embodiment of the present utility model;

[0082] Figure 4 This is a schematic diagram of the base unit according to an embodiment of the present utility model;

[0083] Figure 5 This is a schematic diagram (a) of a drug injection unit according to an embodiment of the present invention;

[0084] Figure 6 This is a schematic diagram of a drive unit according to an embodiment of the present utility model;

[0085] Figure 7 This is a schematic diagram of a control unit according to an embodiment of the present utility model;

[0086] Figure 8 This is a schematic diagram (II) of the spraying wristband device according to an embodiment of the present utility model;

[0087] Figure 9 This is a schematic diagram (II) of the main body unit according to an embodiment of the present utility model;

[0088] Figure 10 This is a schematic diagram (II) of the drug injection unit according to an embodiment of the present invention.

[0089] Figure 11 This is a schematic diagram (a) of the drug supply unit according to an embodiment of the present utility model;

[0090] Figure 12 This is a schematic diagram (II) of the drug supply unit according to an embodiment of the present utility model;

[0091] Figure 13 This is a schematic diagram (III) of the spraying wristband device according to an embodiment of the present utility model;

[0092] Figure 14 This is a schematic diagram (III) of the main unit according to an embodiment of the present utility model.

[0093] The reference numerals in the attached figures are:

[0094] 100. Main body unit; 101. Housing element; 102. Opening element; 103. Sealing element; 104. First mounting element; 105. Second mounting element; 106. Third mounting element;

[0095] 200. Watchband unit; 201. Watchband component; 202. Heat dissipation component;

[0096] 300. Base unit; 301. Base component; 302. Waterproof component;

[0097] 400. Drug injection unit; 401. First drug storage element; 402. Drug injection element; 403. Support element; 404. Pump element; 405. First valve element; 406. Limiting element; 407. Reset element; 408. First pressure monitoring element; 409. First delivery element;

[0098] 500. Drive unit; 501. Sliding rod element; 502. Fixed rod element; 503. Drive element;

[0099] 600. Control unit; 601. Control element; 602. Communication element; 603. Power supply element;

[0100] 700. Drug supply unit; 701. Second drug storage element; 702. Second conveying element; 703. Third conveying element; 704. Air inlet element; 705. Second valve element; 706. Third valve element; 707. Filter element; 708. Second pressure monitoring element; 709. Fourth conveying element; 710. Liquid inlet element; 711. Fourth valve element;

[0101] 800. Health monitoring unit;

[0102] 900, Positioning Unit. Detailed Implementation

[0103] To make the objectives, technical solutions, and advantages of this application clearer, the application is described and illustrated below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the scope of this application. All other embodiments obtained by those skilled in the art based on the embodiments provided in this application without inventive effort are within the scope of protection of this application.

[0104] Obviously, the accompanying drawings described below are merely some examples or embodiments of this application. Those skilled in the art can apply this application to other similar scenarios based on these drawings without any inventive effort. Furthermore, it is understood that although the efforts made in this development process may be complex and lengthy, for those skilled in the art related to the content disclosed in this application, any changes to design, manufacturing, or production based on the technical content disclosed in this application are merely conventional technical means and should not be construed as insufficient disclosure of the content of this application.

[0105] In this application, the reference to "embodiment" means that a specific feature, structure, or characteristic described in connection with an embodiment may be included in at least one embodiment of this application. The appearance of this phrase in various places in the specification does not necessarily refer to the same embodiment, nor is it a separate or alternative embodiment that is mutually exclusive with other embodiments. It will be explicitly and implicitly understood by those skilled in the art that the embodiments described in this application may be combined with other embodiments without conflict.

[0106] Unless otherwise defined, the technical or scientific terms used in this application shall have the ordinary meaning understood by one of ordinary skill in the art to which this application pertains. The terms “a,” “an,” “an,” “the,” and similar words used in this application do not indicate quantity limitation and may indicate singular or plural. The terms “comprising,” “including,” “having,” and any variations thereof used in this application are intended to cover non-exclusive inclusion; for example, a process, method, system, product, or device that includes a series of steps or units (elements) is not limited to the listed steps or units, but may also include steps or units not listed, or may include other steps or units inherent to these processes, methods, products, or devices. The terms “connected,” “linked,” “coupled,” and similar words used in this application are not limited to physical or mechanical connections, but may include electrical connections, whether direct or indirect. “Multiple” used in this application refers to two or more. “And / or” describes the relationship between related objects, indicating that three relationships may exist; for example, “A and / or B” can represent: A alone, A and B simultaneously, and B alone. The character " / " generally indicates that the preceding and following objects are in an "or" relationship. The terms "first," "second," and "third" used in this application are merely to distinguish similar objects and do not represent a specific ordering of the objects.

[0107] Example 1

[0108] An illustrative embodiment of this utility model, such as Figure 1As shown, a drug-spraying wristband device for use by mental patients includes a main body unit 100, a strap unit 200, a base unit 300, a drug spraying unit 400, at least one drive unit 500, and a control unit 600. The main unit 100 is worn on the patient's wrist; the two ends of the strap unit 200 are connected to the two sides of the main unit 100 to fix the main unit 100 to the patient's wrist; the base unit 300 is disposed inside the main unit 100; the top end of the drug spraying unit 400 is connected to the bottom end of the base unit 300, and the bottom end of the drug spraying unit 400 is slidably connected to the bottom end of the main unit 100, for spraying sedative drugs onto the patient's wrist to temporarily numb the patient's hand; the top end of the drive unit 500 is connected to the base unit 300, and the bottom end of the drive unit 500 is connected to the bottom end of the main unit 100, for driving the base unit 300 to drive the drug spraying unit 400 to reciprocate; the control unit 600 is disposed inside the main unit 100 and is connected to the drug spraying unit 400 and the drive unit 500 respectively.

[0109] In some embodiments, there are two drive units 500. The two drive units 500 are symmetrically arranged on both sides of the drug injection unit 400.

[0110] In some of these embodiments, the sedative drugs include, but are not limited to, midazolam, lidocaine, etc.

[0111] like Figure 2 As shown, the main body unit 100 includes a housing element 101, an opening element 102, a sealing element 103, and a first mounting element 104. The housing element 101 is connected to the watch strap unit 200 on both sides. The housing element 101 houses a base unit 300, a drug injection unit 400, a drive unit 500, and a control unit 600. The opening element 102 is located at the bottom of the housing element 101. The sealing element 103 is located at the opening element 102 and is used to seal the opening element 102. The first mounting element 104 is located at the sealing element 103 and is slidably connected to the drug injection unit 400 for mounting the drug injection unit 400.

[0112] In some of these embodiments, housing element 101 includes, but is not limited to, a protective housing.

[0113] The dimensions of the opening element 102 are matched with the dimensions of the housing element 101. Generally, the radial dimensions (such as length and width) of the opening element 102 are smaller than the radial dimensions (such as outer diameter, length, and width) of the housing element 101 in which it is located.

[0114] In some of these embodiments, the opening element 102 is a first opening.

[0115] The sealing element 103 is detachably connected to the housing element 101. This detachable connection includes, but is not limited to, screw connections.

[0116] The dimensions of the sealing element 103 are matched with the dimensions of the opening element 102. Generally, the radial dimensions (such as outer diameter, length, and width) of the sealing element 103 are equal to the radial dimensions (such as outer diameter, length, and width) of the opening element 102.

[0117] In some of these embodiments, the sealing element 103 is a sealing cap.

[0118] The dimensions of the first mounting element 104 are matched with the dimensions of the sealing element 103. Generally, the radial dimensions (such as outer diameter, length, and width) of the first mounting element 104 are smaller than the dimensions (such as outer diameter, length, and width) of the sealing element 103, and the thickness of the first mounting element 104 is equal to the thickness of the sealing element 103.

[0119] In some of these embodiments, the first mounting element 104 is a first mounting hole.

[0120] like Figure 3 As shown, the watch strap unit 200 includes a watch strap element 201. The two ends of the watch strap element 201 are respectively connected to both sides of the main body unit 100, and are worn on the patient's wrist to secure the main body unit 100.

[0121] Specifically, the two ends of the watch strap element 201 are connected to the housing element 101.

[0122] The connection between the watch strap element 201 and the housing element 101 can be a fixed connection or a detachable connection. The fixed connection includes, but is not limited to, integral molding; the detachable connection includes, but is not limited to, snap-fit.

[0123] The dimensions of the watch strap element 201 are matched with the dimensions of the housing element 101. Generally, the radial dimensions (such as outer diameter, length, and width) of the watch strap element 201 are not greater than the radial dimensions (such as outer diameter, length, and width) of the housing element 101 in which it is located, and the thickness of the watch strap element 201 is not greater than the thickness of the housing element 101.

[0124] In some of these embodiments, the strap element 201 is a watch strap.

[0125] Furthermore, the watchband unit 200 also includes a plurality of heat dissipation elements 202. The plurality of heat dissipation elements 202 are distributed on the watchband element 201 to prevent the wrist from sweating.

[0126] Several heat dissipation elements 202 are spaced apart along the length of the strap element 201.

[0127] The dimensions of the heat dissipation element 202 are matched with the dimensions of the watch band element 201. Generally, the radial dimension (e.g., outer diameter) of the heat dissipation element 202 is smaller than the dimensions (e.g., length, width) of the watch band element 201, and the depth of the heat dissipation element 202 is equal to the thickness of the watch band element 201.

[0128] In some of these embodiments, the heat dissipation element 202 is a heat dissipation hole.

[0129] like Figure 4 As shown, the base unit 300 includes a base element 301. The base element 301 is disposed inside the main body unit 100, and the bottom end of the base element 301 is connected to the top end of the drug spraying unit 400 and the drive unit 500, respectively.

[0130] Specifically, the base element 301 is disposed inside the housing element 101.

[0131] The dimensions of the base element 301 are matched with the dimensions of the housing element 101. Generally, the radial dimensions (such as outer diameter, length, and width) of the base element 301 are smaller than the radial dimensions (such as length and width) of the housing element 101.

[0132] In some of these embodiments, the base element 301 is a mounting base.

[0133] Furthermore, the base unit 300 also includes a waterproof element 302. The waterproof element 302 covers the base element 301, the drug spraying unit 400, and the drive unit 500. The bottom end of the waterproof element 302 is connected to the bottom end of the main body unit 100 for waterproofing.

[0134] Specifically, the bottom end of the waterproof element 302 is connected to the sealing element 103.

[0135] The waterproof element 302 and the sealing element 103 are connected in a detachable manner. The detachable connection method includes, but is not limited to, screw connection.

[0136] The dimensions of the waterproof element 302 are matched with the dimensions of the base element 301. Generally, the radial dimensions (such as outer diameter, length and width) of the waterproof element 302 are larger than the radial dimensions (such as outer diameter, length and width) of the base element 301, and the height of the waterproof element 302 is larger than the height of the base element 301.

[0137] In some of these embodiments, the waterproof element 302 includes, but is not limited to, a waterproof groove.

[0138] like Figure 5As shown, the drug injection unit 400 includes a first drug storage element 401, a drug injection element 402, a support element 403, and a pump element 404. The top end of the first drug storage element 401 is connected to the bottom end of the base unit 300, and the bottom end of the first drug storage element 401 is slidably connected to the bottom end of the main unit 100, for storing sedative drugs. The drug injection element 402 is disposed at the bottom end of the first drug storage element 401 and is slidably connected to the bottom end of the main unit 100, for spraying sedative drugs onto the patient's wrist. Both ends of the support element 403 are connected to the bottom end of the base unit 300, the top end of the support element 403 is connected to the bottom ends of both the base unit 300 and the drive unit 500, and the bottom end of the support element 403 is connected to the main unit 100 and slidably connected to the bottom end of the first drug storage element 401. The pump element 404 is disposed on the support element 403 and connected to the control unit 600, for driving the drug injection element 402 to spray drugs under the action of the control unit 600.

[0139] Specifically, the top end of the first drug storage element 401 is connected to the bottom end of the base element 301, and the bottom end of the first drug storage element 401 is slidably connected to the first mounting element 104; the drug spraying element 402 is slidably connected to the first mounting element 104; and the two ends of the support element 403 are respectively connected to the bottom end of the waterproof element 302.

[0140] The first drug storage element 401 and the base element 301 are connected by a fixed connection or a detachable connection. The fixed connection includes, but is not limited to, integral molding; the detachable connection includes, but is not limited to, screw connection.

[0141] The dimensions of the first drug storage element 401 are matched with the dimensions of the base element 301. Generally, the radial dimension (e.g., outer diameter) of the first drug storage element 401 is smaller than the radial dimension (e.g., outer diameter, length, width) of the base element 301.

[0142] The dimensions of the first drug storage element 401 are matched with the dimensions of the waterproof element 302. Generally, the axial dimension (such as height) of the first drug storage element 401 is greater than the height of the waterproof element 302.

[0143] In some of these embodiments, the first drug storage element 401 is a first drug storage tube.

[0144] The connection between the drug injection element 402 and the first drug storage element 401 is a detachable connection. The detachable connection method includes, but is not limited to, threaded connection and snap-fit ​​connection.

[0145] The dimensions of the drug injection element 402 are matched with the dimensions of the first mounting element 104. Generally, the radial dimension (e.g., outer diameter) of the drug injection element 402 is equal to the radial dimension (e.g., inner diameter) of the first mounting element 104.

[0146] In some of these embodiments, the drug injection element 402 is a nozzle.

[0147] The connection between the support element 403 and the waterproof element 302 (sealing element 103) is a detachable connection. The detachable connection method includes, but is not limited to, screw connection.

[0148] The dimensions of the support element 403 are matched with the dimensions of the waterproof element 302. Generally, the radial dimensions (such as outer diameter, length, and width) of the support element 403 are not greater than the radial dimensions (such as outer diameter, length, and width) of the waterproof element 302 to which it is located.

[0149] The dimensions of the support element 403 are matched with the dimensions of the first drug storage element 401. Generally, the radial dimensions (such as outer diameter, length, and width) of the support element 403 are larger than the radial dimensions (such as outer diameter) of the first drug storage element 401.

[0150] In some embodiments, the support element 403 includes a support plate and a sliding hole. The two ends of the support plate are connected to the waterproof element 302, and the bottom end of the support plate is connected to the sealing element 103. The sliding hole is disposed through the support plate and is slidably connected to the first drug storage element 401.

[0151] In some of these embodiments, pump element 404 is a micropump.

[0152] Furthermore, the drug injection unit 400 also includes a first valve element 405. The first valve element 405 is disposed at the bottom end of the first drug storage element 401 and connected to the control unit 600, and is used to control whether the first drug storage element 401 outputs drug.

[0153] In some of these embodiments, the first valve element 405 is a first electronic valve.

[0154] Furthermore, the drug injection unit 400 also includes a limiting element 406. The limiting element 406 is disposed at the bottom end of the first drug storage element 401 and is connected to the fixing element for limiting the range of motion of the first drug storage element 401.

[0155] The limiting element 406 and the first drug storage element 401 are connected by a fixed connection. The fixed connection method includes, but is not limited to, integral molding and welding.

[0156] The dimensions of the limiting element 406 are matched with the dimensions of the first drug storage element 401. Generally, the radial dimension (e.g., outer diameter) of the limiting element 406 is larger than the radial dimension (e.g., outer diameter) of the first drug storage element 401.

[0157] The dimensions of the limiting element 406 are matched with the dimensions of the supporting element 403. Generally, the radial dimension (e.g., outer diameter) of the limiting element 406 is larger than the radial dimension (e.g., outer diameter) of the sliding hole.

[0158] In some of these embodiments, the limiting element 406 is a limiting plate.

[0159] Furthermore, the drug injection unit 400 also includes a reset element 407. The reset element 407 is sleeved on the first drug storage element 401 and is located at the top of the fixing element, and is used to assist the first drug storage element 401 in resetting.

[0160] Specifically, the reset element 407 is located between the limiting element 406 and the supporting element 403.

[0161] The dimensions of the reset element 407 are matched with the dimensions of the first drug storage element 401. Generally, the radial dimension (e.g., inner diameter) of the reset element 407 is larger than the radial dimension (e.g., outer diameter) of the first drug storage element 401, and the height of the reset element 407 is smaller than the height of the first drug storage element 401.

[0162] The dimensions of the reset element 407 are matched with the dimensions of the support element 403. Generally, the radial dimension (e.g., outer diameter) of the reset element 407 is larger than the radial dimension (e.g., outer diameter) of the sliding hole.

[0163] In some of these embodiments, the reset element 407 is a spring.

[0164] Furthermore, the drug injection unit 400 also includes a first pressure monitoring element 408. The first pressure monitoring element 408 is disposed at the top of the first drug storage element 401 and connected to the control unit 600, and is used to monitor the gas pressure inside the first drug storage element 401.

[0165] In some of these embodiments, the first pressure monitoring element 408 is a first pressure sensor.

[0166] like Figure 6 As shown, the drive unit 500 includes a sliding rod element 501, a fixed rod element 502, and a drive element 503. The sliding rod element 501 is disposed on the side of the drug injection unit 400, with its top end connected to the bottom end of the base unit 300, for pushing the base unit 300 to reciprocate. The fixed rod is disposed at the bottom end of the sliding rod element 501 and slides relative to the sliding rod. The drive element 503 is disposed at the bottom end of the fixed rod element 502 and is connected to the sliding rod element 501, the drug injection unit 400, and the control unit 600, respectively, for driving the sliding rod to reciprocate.

[0167] Specifically, the sliding rod element 501 is connected to the base element 301; the bottom end of the drive element 503 is connected to the support element 403.

[0168] The sliding rod element 501 and the base element 301 are connected in a detachable manner. The detachable connection method includes, but is not limited to, screw connection.

[0169] The dimensions of the sliding rod element 501 are matched with the dimensions of the base element 301. Generally, the radial dimension (e.g., outer diameter) of the sliding rod element 501 is smaller than the radial dimension (e.g., length, width) of the base element 301.

[0170] In some of these embodiments, the sliding rod element 501 is a sliding rod.

[0171] The dimensions of the fixed rod element 502 are matched with the dimensions of the sliding rod element 501. Generally, the radial dimension (e.g., inner diameter) of the fixed rod element 502 is not less than the radial dimension (e.g., outer diameter) of the sliding rod element 501, and the length of the fixed rod element 502 is not less than the length of the sliding rod element 501.

[0172] In some of these embodiments, the fixing rod element 502 is a fixing rod.

[0173] In some of these embodiments, the drive element 503 includes, but is not limited to, a micro motor.

[0174] like Figure 7 As shown, the control unit 600 includes a control element 601, a communication element 602, and a power supply element 603. The control element 601 is located in the main unit 100 and is connected to both the drug injection unit 400 and the drive unit 500. The communication element 602 is located in the main unit 100 and connected to the control element 601 for information transmission. The power supply element 603 is located in the main unit 100 and connected to the control unit 600 for power supply.

[0175] Specifically, the control element 601 is connected to the pump element 404, the first valve element 405, the first pressure monitoring element 408, and the drive element 503, respectively.

[0176] In some of these embodiments, the control element 601 includes, but is not limited to, a microcontroller, a chip, or a processor.

[0177] In some embodiments, the communication element 602 includes, but is not limited to, a Bluetooth module, a WiFi module, a 4G module, and a 5G module.

[0178] In some embodiments, the power supply element 603 is either detachable or non-detachable. When it is detachable, the power supply element 603 can be replaced; when it is non-detachable, the power supply element 603 can be charged.

[0179] In some of these embodiments, the power supply element 603 includes, but is not limited to, a battery.

[0180] How to use this utility model:

[0181] When the monitoring system detects that the patient is engaging in violent behavior that attacks others, the control element 601 controls the drive element 503 to drive the sliding rod element 501 to slide relative to the fixed rod element 502, causing the base element 301 and the first drug storage element 401 to move towards the patient's wrist. The drug spraying element 402 slides relative to the support element 403 and the first mounting element 104 and protrudes from the housing element 101. The pump element 404 drives the drug spraying element 402 to spray sedative drugs onto the patient's wrist according to a preset spraying time to temporarily paralyze the patient's wrist and interfere with the patient's violent behavior. After the spraying is completed, the drive element 503 stops driving, and the reset element 407 restores its deformation and pushes the first drug storage element 401 to move the drug spraying element 402 away from the patient's wrist and into the first mounting element 104.

[0182] The technical effects of this utility model are as follows:

[0183] The base unit is connected to the drive unit and the drug spraying unit respectively, and covers the drive unit and the drug spraying unit. This not only allows the drug spraying unit to slide relative to the main unit, but also makes it waterproof and saves installation space. By using the sliding connection between the drug spraying unit and the main unit, it is possible to spray sedative drugs on the patient's hands in a timely manner to temporarily paralyze them and interfere with the patient's violent behavior towards others. It also prevents the drug from entering the main unit and causing the main unit to get damp, thus solving the problem of the lack of timely intervention devices when mental patients commit violence against others.

[0184] Example 2

[0185] This embodiment is a modified embodiment of embodiment 1.

[0186] like Figure 8 As shown, the spray wristband device also includes a drug supply unit 700. The drug supply unit 700 is located inside the main body unit 100 and is connected to the drug spraying unit 400, and is used to deliver sedative drugs to the drug spraying unit 400 under negative pressure.

[0187] like Figure 9 As shown, the main body unit 100 also includes a second mounting element 105. The second mounting element 105 is disposed on the side of the main body unit 100 and is used to mount the drug supply unit 700.

[0188] Specifically, the second mounting element 105 is disposed through the side of the housing element 101.

[0189] The dimensions of the second mounting element 105 are matched with the dimensions of the housing element 101. Generally, the radial dimensions (such as outer diameter, length, and width) of the second mounting element 105 are smaller than the radial dimensions (such as length and width) of the cross section of the housing element 101 in which it is located.

[0190] In some of these embodiments, the second mounting element 105 is a second mounting hole.

[0191] like Figure 10 As shown, the drug injection unit 400 also includes a first delivery element 409. The first delivery element 409 is disposed at the top of the drug injection unit 400 and connected to the drug supply unit 700, for delivering gas or drug to the drug injection unit 400.

[0192] Specifically, the first delivery element 409 is disposed at the top of the first drug storage element 401 and communicates with the first drug storage element 401, for delivering gas or drug to the first drug storage element 401.

[0193] The dimensions of the first delivery element 409 are matched with the dimensions of the first drug storage element 401. Generally, the radial dimension (e.g., outer diameter) of the first delivery element 409 is smaller than the radial dimension (e.g., outer diameter) of the first drug storage element 401.

[0194] In some of these embodiments, the first conveying element 409 is a first conveying pipe or a first conveying port.

[0195] like Figure 11 As shown, the drug supply unit 700 includes a second drug storage element 701, a second conveying element 702, a third conveying element 703, and an air intake element 704. The second drug storage element 701 is disposed on the base unit 300 and communicates with the drug injection unit 400, and is used to replenish the sedative drug to the drug injection unit 400 after the drug is injected by the drug injection unit 400; the first end of the second conveying element 702 is connected to the bottom end of the second drug storage element 701, and the second end of the second conveying element 702 is connected to the top end of the drug injection unit 400, and is used to convey the sedative drug of the second drug storage element 701 to the drug injection unit 400; the first end of the third conveying element 703 is connected to the top end of the second drug storage element 701, and is used to promptly convey gas to the second drug storage element 701 to balance the pressure of the second drug storage element 701 when the second drug storage element 701 outputs sedative drug; the air inlet element 704 is disposed on the side of the main body unit 100 and communicates with the outside of the main body unit 100, and is communicated with the second end of the third conveying element 703, and is used to convey air to the third conveying element 703.

[0196] Specifically, the bottom end of the second drug storage element 701 is connected to the support element 403 and is located inside the waterproof element 302, for delivering drugs to the first drug storage element 401; the second delivery element 702 is connected to the first delivery element 409; and the air intake element 704 is disposed on the second mounting element 105.

[0197] The second drug storage element 701 is connected to the support element 403 in a detachable manner. The detachable connection method includes, but is not limited to, screw connection.

[0198] The dimensions of the second drug storage element 701 are matched with the dimensions of the waterproof element 302. Generally, the radial dimension (e.g., outer diameter) of the second drug storage element 701 is smaller than the radial dimension (e.g., outer diameter) of the waterproof element 302, and the height of the second drug storage element 701 is smaller than the height of the waterproof element 302.

[0199] The dimensions of the second drug storage element 701 are matched with the dimensions of the support element 403. Generally, the radial dimension (e.g., outer diameter) of the second drug storage element 701 is smaller than the radial dimension (e.g., length, width) of the support element 403.

[0200] In some of these embodiments, the second drug storage element 701 is a second drug storage tube.

[0201] The second conveying element 702 is fixedly connected to the first conveying element 409 (second drug storage element 701). The fixed connection method includes, but is not limited to, integral molding.

[0202] The dimensions of the second conveying element 702 are matched with the dimensions of the first conveying element 409. Generally, the radial dimension (e.g., outer diameter) of the second conveying element 702 is equal to the radial dimension (e.g., outer diameter) of the first conveying element 409.

[0203] The dimensions of the second delivery element 702 are matched with the dimensions of the second drug storage element 701. Generally, the radial dimension (e.g., outer diameter) of the second delivery element 702 is smaller than the radial dimension (e.g., outer diameter) of the second drug storage element 701.

[0204] In some of these embodiments, the second conveying element 702 is a second conveying pipe.

[0205] The third conveying element 703 and the second drug storage element 701 are connected in a fixed manner. The fixed connection method includes, but is not limited to, integral molding.

[0206] The dimensions of the third delivery element 703 are matched with the dimensions of the second drug storage element 701. Generally, the radial dimension (e.g., outer diameter) of the third delivery element 703 is smaller than the radial dimension (e.g., outer diameter, length, width) of the second drug storage element 701.

[0207] In some of these embodiments, the third conveying element 703 is a third conveying tube.

[0208] The air intake element 704 and the third conveying element 703 are connected in a fixed manner. The fixed connection method includes, but is not limited to, integral molding.

[0209] The connection between the intake element 704 and the second mounting element 105 is a detachable connection. The detachable connection method includes, but is not limited to, snap-fit.

[0210] The dimensions of the intake element 704 are matched with the dimensions of the second mounting element 105. Generally, the radial dimensions (such as outer diameter, length, and width) of the intake element 704 are not greater than the radial dimensions (such as outer diameter, length, and width) of the second mounting element 105.

[0211] In some of these embodiments, the air intake element 704 is an air intake port.

[0212] Furthermore, the drug supply unit 700 also includes a second valve element 705. The second valve element 705 is disposed on the second delivery element 702 and connected to the control unit 600, and is used to prevent the drug from the drug injection unit 400 from flowing back into the drug supply unit 700.

[0213] Specifically, the second valve element 705 is connected to the control element 601 to prevent the drug in the first drug storage element 401 from flowing into the second drug storage element 701.

[0214] In some of these embodiments, the second valve element 705 is a second electronic valve or a first check valve.

[0215] Furthermore, the drug supply unit 700 also includes a third valve element 706. The third valve element 706 is disposed on the third delivery element 703 and connected to the control unit 600, and is used to control the opening and closing of the third delivery element 703.

[0216] Specifically, the third valve element 706 is connected to the control element 601.

[0217] In some of these embodiments, the third valve element 706 is a third electronic valve or a second check valve.

[0218] Furthermore, the drug supply unit 700 also includes a filter element 707. The filter element 707 is disposed at the end of the air intake element 704 and connected to the main body unit 100, and is used to filter the air entering the air intake element 704.

[0219] The filter element 707 and the intake element 704 are connected in a detachable manner. The detachable connection method includes, but is not limited to, screw connection and snap-fit ​​connection.

[0220] The dimensions of the filter element 707 are matched with the dimensions of the second mounting element 105. Generally, the radial dimension (e.g., outer diameter) of the filter element 707 is not greater than the radial dimension (e.g., outer diameter) of the second mounting element 105.

[0221] The dimensions of the filter element 707 are matched with the dimensions of the intake element 704. Generally, the radial dimension (e.g., outer diameter) of the filter element 707 is equal to the radial dimension (e.g., outer diameter) of the intake element 704.

[0222] In some of these embodiments, the filter element 707 includes, but is not limited to, a filter screen.

[0223] Furthermore, the drug supply unit 700 also includes a second pressure monitoring element 708. The second pressure monitoring element 708 is disposed in the second drug storage element 701 and connected to the control unit 600, and is used to monitor the gas pressure inside the second drug storage element 701.

[0224] Specifically, the second pressure monitoring element 708 is connected to the control element 601.

[0225] In some of these embodiments, the second pressure monitoring element 708 is a second pressure sensor.

[0226] The usage method of this embodiment is as follows:

[0227] When the sedative drug is output from the first drug storage element 401, due to the negative pressure, the sedative drug inside the second drug storage element 701 is promptly replenished into the first drug storage element 401 by the second delivery element 702 via the first delivery element 409. The second valve element 705 prevents the drug in the first drug storage element 401 from flowing back into the second drug storage element 701. At the same time, air enters the second drug storage element 701 through the filter element 707, the air intake element 704, and the third delivery element 703 to balance the pressure difference inside the second drug storage element 701. The second pressure monitoring element 708 monitors the pressure inside the second drug storage element 701 and transmits it to the control element 601. When the pressure exceeds the preset range, the control element 601 controls the opening of the third valve element 706, connecting the air intake element 704 and the third delivery element 703 to the second drug storage element 701, and balancing the pressure inside the second drug storage element 701 so that the pressure inside the second drug storage element 701 meets the preset range.

[0228] The technical effects of this embodiment are as follows:

[0229] The drug supply unit can automatically supply drugs to the drug spraying unit in a timely manner through negative pressure, ensuring the normal operation of the drug spraying unit.

[0230] Example 3

[0231] This embodiment is a modified embodiment of Embodiments 1 and 2.

[0232] like Figure 12 As shown, the drug supply unit 700 also includes a fourth delivery element 709, a liquid inlet element 710, and a fourth valve element 711. The first end of the fourth delivery element 709 is connected to the second drug storage element 701, and the second end of the fourth delivery element 709 is connected to the main body unit 100 for delivering sedative drugs to the second drug storage element 701. The liquid inlet element 710 is connected to the second end of the fourth delivery element 709 and to the side of the main body unit 100 for delivering drugs to the fourth delivery element 709. The fourth valve element 711 is located at the second end of the fourth delivery element 709 and is connected to the control unit 600 for controlling the opening and closing of the fourth delivery element 709.

[0233] Specifically, the liquid inlet element 710 is disposed on the second mounting element 105; the fourth valve element 711 is connected to the control element 601.

[0234] The fourth conveying element 709 and the second drug storage element 701 are connected by a fixed connection. The fixed connection method includes, but is not limited to, integral molding.

[0235] The dimensions of the fourth delivery element 709 are matched with the dimensions of the second drug storage element 701. Generally, the radial dimension (e.g., outer diameter) of the fourth delivery element 709 is smaller than the radial dimension (e.g., outer diameter, length, width) of the second drug storage element 701.

[0236] In some of these embodiments, the fourth conveying element 709 is a fourth conveying tube.

[0237] The liquid inlet element 710 and the fourth delivery element 709 are connected in a fixed manner. The fixed connection method includes, but is not limited to, integral molding.

[0238] The dimensions of the liquid inlet element 710 are matched with the dimensions of the second mounting element 105. Generally, the radial dimension (e.g., outer diameter) of the liquid inlet element 710 is not greater than the radial dimension (e.g., inner diameter) of the second mounting element 105.

[0239] In some of these embodiments, the liquid inlet element 710 is a liquid inlet hole or a liquid inlet connector.

[0240] In some of these embodiments, the fourth valve element 711 is a fourth electronic valve.

[0241] The usage method of this embodiment is as follows:

[0242] After the medication is sprayed onto the patient, the staff can operate the control element 601 through the control terminal to open the fourth valve element 711 and use the liquid inlet element 710 to replenish the sedative medication to the second drug storage element 701, ensuring that the second drug storage element 701 stores sufficient sedative medication for the next use.

[0243] The technical effects of this embodiment are as follows:

[0244] The fourth delivery element, liquid inlet element, and fourth valve element can be used to replenish the sedative drug in the second drug storage element in a timely manner without opening the main unit, making it more convenient to use.

[0245] Example 4

[0246] This embodiment is a modified embodiment of Embodiments 1 to 3.

[0247] like Figure 13 As shown, the spraying wristband device also includes a health monitoring unit 800. The health monitoring unit 800 is located in the main unit 100 and connected to the control unit 600, and is used to monitor the patient's health information.

[0248] like Figure 14 As shown, the main body unit 100 also includes a third mounting element 106. The third mounting element 106 is disposed at the bottom end of the main body unit 100 and is used to mount the health monitoring unit 800.

[0249] Specifically, the third mounting element 106 is disposed on the sealing element 103 for mounting the health monitoring unit 800.

[0250] The dimensions of the third mounting element 106 are matched with the dimensions of the sealing element 103. Generally, the radial dimensions (such as outer diameter, length, and width) of the third mounting element 106 are smaller than the radial dimensions (such as outer diameter, length, and width) of the sealing element 103.

[0251] In some of these embodiments, the third mounting element 106 is a third mounting hole.

[0252] The health monitoring unit 800 is located inside the housing element 101 and is connected to the third mounting element 106 and the control element 601.

[0253] In some of these embodiments, the health monitoring unit 800 includes, but is not limited to, a temperature sensor and a heart rate monitor.

[0254] Furthermore, such as Figure 13 As shown, the spray wristband device also includes a positioning unit 900. The positioning unit 900 is located in the main unit 100 and connected to the control unit 600, used to acquire the patient's location information.

[0255] Specifically, the positioning unit 900 is disposed on the housing element 101 and connected to the control element 601.

[0256] In some of these embodiments, the positioning unit 900 includes, but is not limited to, a GPS locator and a BeiDou locator.

[0257] The usage method of this embodiment is as follows:

[0258] The main unit 100 is worn on the patient's wrist. The health monitoring unit 800 monitors the patient's health information and transmits it to the control element 601, which then transmits it to the control system. The positioning unit 900 monitors the patient's location information in real time and transmits it to the control element 601, which then transmits it to the control system. Staff can view the patient's health and location information in real time from the control terminal.

[0259] The technical effects of this embodiment are as follows:

[0260] The health monitoring unit can be used to obtain the patient's health status in real time so that measures can be taken in time when problems occur in the patient's health information; the positioning unit can be used to obtain the patient's location information in real time so that the patient can be found in time when needed.

[0261] The above description is only a preferred embodiment of the present utility model and does not limit the implementation method and protection scope of the present utility model. Those skilled in the art should realize that all solutions obtained by equivalent substitutions and obvious changes made based on the description and illustrations of the present utility model should be included within the protection scope of the present utility model.

Claims

1. A spray wristband device for use by mental patients, characterized in that, The application relates to a wrist-worn tranquilizer device. The device comprises: a main unit, which is worn on the wrist of a patient; a watchband unit, the two ends of which are connected to the two sides of the main unit respectively, and which is used for fixing the main unit on the wrist of the patient; a base unit, which is arranged in the main unit; a drug spraying unit, the top end of which is connected to the bottom end of the base unit, and the bottom end of which is slidably connected to the bottom end of the main unit, and which is used for spraying tranquilizer on the wrist of the patient to make the hand of the patient paralytic temporarily; at least one driving unit, the top end of which is connected to the base unit, and the bottom end of which is connected to the bottom end of the main unit, and which is used for driving the base unit to drive the drug spraying unit to make reciprocating motion; 2. The medicine spraying bracelet device according to claim 1, wherein, a control unit, which is arranged in the main unit, and is connected to the drug spraying unit and the driving unit respectively. The main unit comprises: a shell element, the two sides of which are connected to the watchband unit respectively, and the inside of which is provided with the base unit, the drug spraying unit, the driving unit and the control unit; an opening element, which is arranged at the bottom end of the shell element; a sealing element, which is arranged on the opening element, and is used for sealing the opening element; a first mounting element, which is arranged on the sealing element, and is slidably connected to the drug spraying unit, and which is used for mounting the drug spraying unit; and / or The watchband unit comprises: a watchband element, the two ends of which are connected to the two sides of the main unit respectively, and which is used for being worn on the wrist of the patient to fix the main unit; and / or The base unit comprises:

3. The medicine spraying bracelet device according to claim 2, wherein, a base element, which is arranged in the main unit, and the bottom end of which is connected to the top end of the drug spraying unit and the driving unit respectively. The watchband unit further comprises: a plurality of heat dissipation elements, which are arranged on the watchband element, and are used for preventing the wrist from sweating; and / or The base unit further comprises:

4. The medicine spraying bracelet device according to claim 1, wherein, a waterproof element, which covers the base element, the drug spraying unit and the driving unit, and the bottom end of which is connected to the bottom end of the main unit, and which is used for preventing water. The drug spraying unit comprises: a first drug storage element, the top end of which is connected to the bottom end of the base unit, and the bottom end of which is slidably connected to the bottom end of the main unit, and which is used for storing tranquilizer; a drug spraying element, which is arranged at the bottom end of the first drug storage element, and is slidably connected to the bottom end of the main unit, and which is used for spraying tranquilizer on the wrist of the patient; a support element, the two ends of which are connected to the bottom end of the base unit respectively, the top end of which is connected to the bottom end of the base unit and the driving unit respectively, the bottom end of which is connected to the main unit, and is slidably connected to the bottom end of the first drug storage element. A pump element is arranged on the support element and connected with the control unit, and is used to drive the medicine spraying element to spray medicine under the action of the control unit; and / or The driving unit comprises: A sliding rod element is arranged on the side of the medicine spraying unit, and the top end of the sliding rod is connected with the bottom end of the base unit, and is used to push the base unit to make reciprocating motion; A fixed rod element is arranged on the bottom end of the sliding rod element and slides relative to the sliding rod; A driving element is arranged on the bottom end of the fixed rod element and is connected with the sliding rod element, the medicine spraying unit and the control unit respectively, and is used to drive the sliding rod to make reciprocating motion; and / or The control unit comprises: A control element is arranged on the main body unit, and the control element is connected with the medicine spraying unit and the driving unit respectively; A communication element is arranged on the main body unit and is connected with the control element, and is used for information transmission; A power supply element is arranged on the main body unit and is connected with the control unit, and is used for power supply.

5. The medicated bracelet apparatus of claim 4, wherein, The medicine spraying unit further comprises: A first valve element is arranged on the bottom end of the first medicine storage element and is connected with the control unit, and is used to control whether the first medicine storage element outputs medicine; and / or A limiting element is arranged on the bottom end of the first medicine storage element and is connected with the fixed element, and is used to limit the movement range of the first medicine storage element; and / or A reset element is sleeved on the first medicine storage element and is located at the top end of the fixed element, and is used to assist the first medicine storage element to reset; and / or A first pressure monitoring element is arranged on the top end of the first medicine storage element and is connected with the control unit, and is used to monitor the gas pressure inside the first medicine storage element.

6. The medicine spraying bracelet device according to any one of claims 1-5, wherein, Further comprising: A medicine supply unit is arranged inside the main body unit and is connected with the medicine spraying unit, and is used to deliver calming medicine to the medicine spraying unit under the action of negative pressure; and / or A health monitoring unit is arranged on the main body unit and is connected with the control unit, and is used to monitor the health information of the patient; and / or A positioning unit is arranged on the main body unit and is connected with the control unit, and is used to obtain the position information of the patient.

7. The medicated bracelet apparatus of claim 6, wherein, The main body unit further comprises: A second mounting element is arranged on the side of the main body unit and is used to mount the medicine supply unit; and / or The main body unit further comprises: A third mounting element is arranged on the bottom end of the main body unit and is used to mount the health monitoring unit; and / or The medicine spraying unit further comprises: A first delivery element is arranged on the top end of the medicine spraying unit and is connected with the medicine supply unit, and is used to deliver gas or medicine to the medicine spraying unit.

8. The medicated bracelet apparatus of claim 6 wherein, The medicine supply unit comprises: a second medicine storage element, disposed in the base unit and in communication with the medicine spraying unit, for replenishing the medicine spraying unit with the sedative medicine after the medicine spraying unit sprays the medicine; a second conveying element, a first end of which is connected to a bottom end of the second medicine storage element, and a second end of which is connected to a top end of the medicine spraying unit, for conveying the sedative medicine in the second medicine storage element to the medicine spraying unit; a third conveying element, a first end of which is connected to a top end of the second medicine storage element, for conveying gas to the second medicine storage element in time to balance the pressure in the second medicine storage element when the second medicine storage element outputs the sedative medicine; an air inlet element, disposed on a side of the main body unit, in communication with the outside of the main body unit, and in communication with a second end of the third conveying element, for conveying air to the third conveying element.

9. The medicated bracelet apparatus of claim 8, wherein, The medicine supply unit further comprises: a second valve element, disposed in the second conveying element and connected to the control unit, for preventing the medicine in the medicine spraying unit from flowing back into the medicine supply unit; and / or a third valve element, disposed in the third conveying element and connected to the control unit, for controlling the opening and closing of the third conveying element; and / or a filter element, disposed at an end of the air inlet element and connected to the main body unit, for filtering the air entering the air inlet element; and / or a second pressure monitoring element, disposed in the second medicine storage element and connected to the control unit, for monitoring the gas pressure inside the second medicine storage element.

10. The spray ring device according to claim 8 or 9, characterized in that The medicine supply unit further comprises: a fourth conveying element, a first end of which is in communication with the second medicine storage element, and a second end of which is disposed in the main body unit, for conveying the sedative medicine to the second medicine storage element; a liquid inlet element, in communication with the second end of the fourth conveying element and connected to a side of the main body unit, for conveying the medicine to the fourth conveying element; a fourth valve element, disposed at the second end of the fourth conveying element and connected to the control unit, for controlling the opening and closing of the fourth conveying element.

Images